• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Expression of cell adhesion molecules E-, P-, N-cadherin-6, -11, and -13 in renal cell carcinomas. An immunohistochemical study

Research Project

Project/Area Number 09671651
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Urology
Research InstitutionKeio University

Principal Investigator

ASAKURA Hirotaka (1999)  Keio Univ., Dept.of Urology, Assistant Professor, 医学部, 専任講師 (50175840)

中島 洋介 (1997-1998)  慶應義塾大学, 医学部, 講師 (20172322)

Co-Investigator(Kenkyū-buntansha) OHIGASHI Takashi  Keio Univ., Dept.of Urology, Assistant Professor, 医学部, 専任講師 (80185371)
OYA Mototsugu  Keio Univ., Dept.of Urology, Assistant, 医学部, 助手 (00213885)
TACHIBANA Masaaki  Keio Univ., Dept.of Urology, Associate Professor, 医学部, 助教授 (70129526)
朝倉 博孝  慶應義塾大学, 医学部, 助手 (50175840)
Project Period (FY) 1997 – 1999
Project Status Completed (Fiscal Year 1999)
Budget Amount *help
¥3,200,000 (Direct Cost: ¥3,200,000)
Fiscal Year 1999: ¥1,000,000 (Direct Cost: ¥1,000,000)
Fiscal Year 1998: ¥1,000,000 (Direct Cost: ¥1,000,000)
Fiscal Year 1997: ¥1,200,000 (Direct Cost: ¥1,200,000)
Keywordscadherin 6 / N-cadherin / E-cadherin / renal cell carcinoma / grade / metastasis / cadherin 6 / Cadherin-6 / N-Cadherin / E-Cadherin / cadherin-6 / P-cadherin / 浸潤・転移
Research Abstract

Expression of six cadherin molecules, E-, P-, N-cadherin, cadhelin-6,-11, and -13, in renal cell carcinomas (RCC), was investigated in order to elucidate whether these molecules are involved in the progression. Northern blot analysis of seven RCC cell lines showed that N-cadherin and cadhelin-6 were strongly expressed in all and 5 lines, respectively, whereas E, and P-cadherin were not detected at all. In KU2 cells transplanted to SCID mice, N-cadherin and cadhelin-6 were detected faintly in the subcutaneous tumors, but not in the metastatic tumors. Each cadherin expression in 30 surgically resected RCC was examined by immunostaining using frozen sections. The number of tumors expressing E-cadherin was significantly smaller than that of N-cadherin or cadhelin-6 (p<0.005). High grade tumors tended to have neither E-cadherin nor cadhelin-6 expression. In five metastatic tumors to the lung, cadhelin-6 was expressed in all, N-cadherin in 4, but E-cadherin in one. Using paraffin-embedded specimens of surgically resected RCC, expression of E- and N-cadherin was also examined immunohistochemically, and correlation between pathological tumor extension (pT classification) and the cadherin expression was analyzed. The patterns of each cadherin expression were almost the same as those in the aforementioned frozen specimens. In 10 primary tumors having metastatic lesions, N- and E-cadherin were detected in 8 and 4, respectively, and coexpression of E- and N-cadherin was observed in 3 tumors. High pT tumors tended to have N-cadherin expression. These results suggested that expression of N-cadherin or cadhelin-6, and absence of E-cadhelin expression might be correlated to the progression of RCC, although further studies will be necessary to draw. A conclusion

Report

(4 results)
  • 1999 Annual Research Report   Final Research Report Summary
  • 1998 Annual Research Report
  • 1997 Annual Research Report
  • Research Products

    (3 results)

All Other

All Publications (3 results)

  • [Publications] Tachibana M,et al: "Constituve production of multiple cytokines and a human chorionic gonadotrophin beta-subunit by a human bladder cancer cell line (KU-19-19) : possible demonstration of totipotential differentiation." British Journal of Cancer. 76(2). 163-174 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] Tachibana M,et al: "Granulocyte colony-stimulating factor receptor expression on human transitional cell carcinoma of the bladder." British Journal of Cancer. 75(10). 1489-1496 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] Tachibana M,et al: "Role of proliferative activity estimated by bromodeoxyuridine labeling index in determining predictive factors recurrence in superficial intermediately malignant bladder tumors." Journal of Urology. 156(1). 63-69 (1997)

    • Related Report
      1997 Annual Research Report

URL: 

Published: 1997-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi